Evidence map›Paper›PMID 29164637›Full record

ArticleStatistics in medicine2018

Internal pilot design for balanced repeated measures.

Xinrui Zhang, Keith E Muller, Maureen M Goodenow, Yueh-Yun Chi

Abstract read
In one paragraph

Article in Statistics in medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xinrui ZhangNovartis Pharmaceuticals Corporation, East Hanover, NJ, USA.ORCID 0000-0001-8451-5893
Keith E MullerDepartment of Health Outcomes and Policy, University of Florida, Gainesville, FL, USA.
Maureen M GoodenowNational Institutes of Health, Bethesda, MD, USA.
Yueh-Yun ChiDepartment of Biostatistics, University of Florida, Gainesville, FL, USA.ORCID 0000-0003-1792-0578

Funding

NCTN BIQSFP ANBL1531 (NRT)U10CA180886 · NCI · PUBLIC HEALTH INSTITUTE · PI Douglas S. Hawkins · 2014 to 2026
$390.6M
COG SDMC - Statistics CoreU10CA180899 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TODD A ALONZO · 2014 to 2026
$132.8M
Mechanisms & Consequences of Vascular Adaptations in Pregnancies Conceived by ARTP01HD065647 · NICHD · UNIVERSITY OF FLORIDA · PI CONRAD, KIRK P · 2011 to 2016
$6.1M
Substance Use and Immunity in HIV+ Adolescents by Systems BiologyR01DA031017 · NIDA · UNIVERSITY OF FLORIDA · PI YIN, LI · 2010 to 2014
$4.4M
Vitamin B6 Effects on One-Carbon MetabolismR01DK072398 · NIDDK · UNIVERSITY OF FLORIDA · PI GREGORY, JESSE F. · 2005 to 2013
$3.3M
Methods and Software for Lifecourse Epidemiology Data and Sample Size AnalysisR01GM121081 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI DABELEA, DANA, GLUECK, DEBORAH HELEN · 2016 to 2019
$2.6M
Multilevel and Longitudinal Study Sample Size Tools for Behavioral ScientistsR01DE020832 · NIDCR · UNIVERSITY OF FLORIDA · PI MULLER, KEITH E · 2011 to 2014
$2.3M
Advanced Postgraduate Program in Clinical InvestigationK30RR022258 · NCRR · UNIVERSITY OF FLORIDA · PI LIMACHER, MARIAN C. · 2005 to 2009
$1.3M
A Master Course on Power for Multilevel and Longitudinal Health Behavior StudiesR25GM111901 · NIGMS · UNIVERSITY OF FLORIDA · PI GLUECK, DEBORAH HELEN, MULLER, KEITH E · 2014 to 2018
$1.0M
Power and Sample Size for Multilevel and Longitudinal Designs in Health ResearchG13LM011879 · NLM · UNIVERSITY OF FLORIDA · PI GLUECK, DEBORAH HELEN, MULLER, KEITH E · 2014 to 2016
$147k
NCI NIH HHS U10 CA180886NCI NIH HHS U10 CA180899NCRR NIH HHS K30 RR022258NICHD NIH HHS P01 HD065647NIDA NIH HHS R01 DA031017NIDCR NIH HHS R01 DE020832NIDDK NIH HHS R01 DK072398NIGMS NIH HHS R01 GM121081NIGMS NIH HHS R25 GM111901NLM NIH HHS G13 LM011879
6 · The paper itself

Abstract

Repeated measures are common in clinical trials and epidemiological studies. Designing studies with repeated measures requires reasonably accurate specifications of the variances and correlations to select an appropriate sample size. Underspecifying the variances leads to a sample size that is inadequate to detect a meaningful scientific difference, while overspecifying the variances results in an unnecessarily large sample size. Both lead to wasting resources and placing study participants in unwarranted risk. An internal pilot design allows sample size recalculation based on estimates of the nuisance parameters in the covariance matrix. We provide the theoretical results that account for the stochastic nature of the final sample size in a common class of linear mixed models. The results are useful for designing studies with repeated measures and balanced design. Simulations examine the impact of misspecification of the covariance matrix and demonstrate the accuracy of the approximations in controlling the type I error rate and achieving the target power. The proposed methods are applied to a longitudinal study assessing early antiretroviral therapy for youth living with HIV.

Indexed as

Linear ModelsSample SizeClinical Trials as TopicComputer SimulationHumansLongitudinal StudiesMultivariate AnalysisPilot ProjectsResearch DesignStochastic Processesfixed effects inferencelinear mixed modelpowersample sizeUNIREP

Identifiers

PMID29164637
PMCPMC5768471

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.